Delivery Order SPE2DB22D2007-SPE2DB24FJ0ES
Award Date 3/5/24
Potential Completion Date 3/6/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $1,642.44 worth of Qsymia 11.25mg-69mg tablets (30-count) under a firm fixed-price contract. The award was made competitively without set-aside restrictions and is scheduled for completion by September 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) valued at $1,045.63 for Qsymia 15 mg-92 mg capsules (30-count). The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was structured as a firm fixed price contract with no set-aside designation. The place of performance is the vendor's Conshohocken facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count) valued at $1,614.09, with an ultimate completion date of September 26, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing...
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Qsymia 11.25 mg-69 mg capsules (30-count unit) with a firm fixed price ceiling value of $2,037.36. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded under an existing contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of QSYMIA 15 mg-92 mg capsules (30-count units) with a firm fixed price ceiling value of $1,643.28. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 22, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,876.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units), a prescription medication used in weight management treatment. The contract, which was competitively awarded with no set-aside designation, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, utilizing...
- This is a delivery order contract awarded by the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of the prescription drug QSYMIA 7.5MG-46MG 30S. The contract, which is a firm fixed price type, has a ceiling value of $1,507.20 and runs through July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Qsymia 15 mg-92 mg capsules (30-count units) with a ceiling value of $1,732.83. This firm fixed-price delivery order, with an ultimate completion date of May 14, 2025, represents a pediatric or standard-dose pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,315.44 contract requires Amerisourcebergen Drug Corp's Corporate Office division in Conshohocken, Pennsylvania to provide a variety of pharmaceutical products and medical supplies in support of military treatment programs and facilities. This delivery order is part...